Safety, Tolerability, and Efficacy of Cariprazine in Patients With Bipolar Depression
|ClinicalTrials.gov Identifier: NCT01396447|
Recruitment Status : Completed
First Posted : July 18, 2011
Last Update Posted : March 18, 2015
Gedeon Richter Ltd.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||January 2014|
|Study Completion Date :||March 2014|
|Certification/Extension First Submitted :||February 27, 2015|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Durgam S, Earley W, Lipschitz A, Guo H, Laszlovszky I, Németh G, Vieta E, Calabrese JR, Yatham LN. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression. Am J Psychiatry. 2016 Mar 1;173(3):271-81. doi: 10.1176/appi.ajp.2015.15020164. Epub 2015 Nov 6.